Registry for patients with poor grade aneurysmal subarachnoid hemorrhage
Official title: Poor Grade Aneurysmal Subarachnoid Hemorrhage Multicentric Study Group
Run by IRCCS San Raffaele · NCT04945603 · Data updated 2026-11-12
This study is trying to understand how to better treat and predict outcomes for patients with severe brain bleeding caused by aneurysms, looking at both immediate and long-term effects.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 800 (estimated) |
| Sponsor | IRCCS San Raffaele Academic / other |
| Locations | 10 sites (Bergamo and 9 other locations) |
| Status | Recruiting |
| Started | May 25, 2021 |
| Main results expected | December 31, 2025 |
| Study ends | December 31, 2028 |
| Registry record updated | November 29, 2023 |
| Trial ID | NCT04945603 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include patients aged 18 and older admitted for poor grade aneurysmal subarachnoid hemorrhage classified as IV-V according to the WFNS classification.
✕Probably not a fit
Patients younger than 18, pregnant or breastfeeding women, and those with aneurysmal subarachnoid hemorrhage due to trauma or vascular malformations other than cerebral aneurysms may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This multicentric registry aims to define outcomes, predictors, treatment effects, and modifiers in patients suffering from poor grade aneurysmal subarachnoid hemorrhage. The research focuses on three main areas: early brain injury predictors in the emergency department, delayed brain injury predictors in the neurocritical care unit, and treatment strategies. Additionally, it investigates the incidence and impact of delayed cerebral ischemia and the long-term follow-up of patients who may experience significant improvement after 6-12 months. Standard management will be provided according to established guidelines.
Why it matters
Potential benefit: If successful, this study could improve understanding of treatment outcomes and predictors, leading to better management strategies for patients with poor grade aneurysmal subarachnoid hemorrhage.
How similar studies have gone: Other studies have explored similar predictors and outcomes in subarachnoid hemorrhage, suggesting that this approach has potential for meaningful insights.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients admitted to the emergency department because of aneurysmal subarachnoid hemorrhage of poor grade (IV-V) according to the WFNS classification. Exclusion Criteria: * Patients younger than 18 years old. * Pregnant or breast-feeding patients. * Aneurysmal subarachnoid hemorrhage due to trauma or vascular malformations other than cerebral aneurysms.
Where it's running
-
IRCCS Bellaria
Bologna, Italy Recruiting -
Azienda Ospedaliera Spedali Civili
Brescia, Italy Recruiting -
Ospedale Vito Fazzi
Lecce, Italy Recruiting -
IRCCS San Raffaele
Milan, Italy Recruiting -
Ospedale Maggiore della Città di Novara
Novara, Italy Recruiting -
Azienda Ospedaliero-Universitaria di Parma
Parma, Italy Recruiting
Show 4 more locations
-
Ospedale Santissima Annunziata
Taranto, Italy Recruiting -
Azienda Ospedaliera Universitaria Integrata
Verona, Italy Recruiting -
ASST Ospedale Papa Giovanni XXIII
Bergamo, Italy Active not recruiting -
Policlinico Universitario Agostino Gemelli
Roma, Italy Active not recruiting
Study contacts
- Principal investigator: Pietro Panni, P.I., M.D. — Department of Neuroradiology, Department of Neurosurgery
- Study coordinator: Pietro Panni, P.I., M.D.
- Email: panni.pietro@hsr.it
- Phone: +393406311389
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Understanding hemorrhage subtypes in perimesencephalic SAH and basilar artery perforator aneurysms
This study tests whether different bleeding patterns in pmSAH, including potential basilar artery perforator aneurysms, relate to patient outcomes using a patient-reported EQ-5D measure.
-
Augmented kidney clearance in neurocritical care
This project will test whether adults in the neuro-ICU with severe brain injury, stroke, seizures, or brain infections have faster kidney clearance (ARC) that can lower antiseizure and antibiotic drug levels.
-
Lidocaine with or without steroid infusion into the middle meningeal artery for headaches after aneurysmal subarachnoid hemorrhage
This study will try an infusion of lidocaine, with or without a steroid, into the middle meningeal artery to see if it reduces severe headaches and opioid use in adults recovering from aneurysmal subarachnoid hemorrhage.
-
Nimodipine blood levels and enantiomer differences in aneurysmal subarachnoid hemorrhage.
This project will test whether different amounts and the two forms of nimodipine get into the blood of adults with aneurysmal subarachnoid hemorrhage and whether that relates to their recovery.
-
Understanding brain and heart injuries after bleeding in the brain
This study looks at how bleeding in the brain affects both the brain and the heart in adults to better understand the connection between these injuries.
-
Remote ischemic conditioning after aneurysm clipping for ruptured brain aneurysms
This test tries brief cycles of limb cuff inflation (remote ischemic conditioning) to see if it is safe and helps recovery in adults after surgical clipping of a ruptured brain aneurysm (aneurysmal subarachnoid hemorrhage).
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.